MorphoSys AG (NASDAQ:MOR)

5.05
Delayed Data
As of Jul 01
 +0.22 / +4.55%
Today’s Change
4.35
Today|||52-Week Range
19.83
-46.39%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$684.3M

Company Description

MorphoSys AG operates as a commercial-stage biopharmaceutical company. It uses groundbreaking science and technologies to discover, develop, and deliver innovative cancer medicines to patients. The firm also engages in the development and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.

Contact Information

MorphoSys AG
Semmelweisstrasse 7
Planegg Bayern (bavaria) 82152
P:(498) 989-9270
Investor Relations:
498989927179

Employees

Shareholders

Other institutional1.63%
Mutual fund holders0.47%
Individual stakeholders--

Top Executives

Jean-Paul KressCEO & Chairman-Management Board
Sung H. LeeChief Financial Officer
Malte PetersChief Research & Development Officer
Daniel PalmacciGlobal Head-Technical Operations
Charlotte LohmannSenior Vice President & General Counsel